The global Osteoarthritis Drugs market was valued at US$ 9238.5 million in 2023 and is anticipated to reach US$ 11730 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.

Osteoarthritis Drugs Market

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.

This report aims to provide a comprehensive presentation of the global market for Osteoarthritis Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Osteoarthritis Drugs.

Report Scope

The Osteoarthritis Drugs market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Osteoarthritis Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Osteoarthritis Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Osteoarthritis Drugs Market Report

Report Metric	Details
Report Name	Osteoarthritis Drugs Market
Accounted market size in 2023	US$ 9238.5 million
Forecasted market size in 2030	US$ 11730 million
CAGR	3.4%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Oral Injection External
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Osteoarthritis Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Osteoarthritis Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Osteoarthritis Drugs Market growing?

Ans: The Osteoarthritis Drugs Market witnessing a CAGR of 3.4% during the forecast period 2024-2030.

What is the Osteoarthritis Drugs Market size in 2030?

Ans: The Osteoarthritis Drugs Market size in 2030 will be US$ 11730 million.

What is the Osteoarthritis Drugs Market share by region?

Ans: North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.

What is the market share of major companies in Osteoarthritis Drugs Market?

Ans: Top 5 companies occupied about 66% market share.

Who are the main players in the Osteoarthritis Drugs Market report?

Ans: The main players in the Osteoarthritis Drugs Market are Johnson & Johnson, Pfizer, Eli Lilly, Abbott, GlaxoSmithKline, Sanofi, Flexion Therapeutics

What are the Application segmentation covered in the Osteoarthritis Drugs Market report?

Ans: The Applications covered in the Osteoarthritis Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Osteoarthritis Drugs Market report?

Ans: The Types covered in the Osteoarthritis Drugs Market report are Oral, Injection, External

1 Osteoarthritis Drugs Market Overview

1.1 Product Overview and Scope of Osteoarthritis Drugs

1.2 Osteoarthritis Drugs Segment by Type

1.2.1 Global Osteoarthritis Drugs Market Value Comparison by Type (2024-2030)

1.2.2 Oral

1.2.3 Injection

1.2.4 External

1.3 Osteoarthritis Drugs Segment by Application

1.3.1 Global Osteoarthritis Drugs Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Osteoarthritis Drugs Market Size Estimates and Forecasts

1.4.1 Global Osteoarthritis Drugs Revenue 2019-2030

1.4.2 Global Osteoarthritis Drugs Sales 2019-2030

1.4.3 Global Osteoarthritis Drugs Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Osteoarthritis Drugs Market Competition by Manufacturers

2.1 Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2019-2024)

2.2 Global Osteoarthritis Drugs Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Osteoarthritis Drugs Average Price by Manufacturers (2019-2024)

2.4 Global Osteoarthritis Drugs Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Osteoarthritis Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Osteoarthritis Drugs, Product Type & Application

2.7 Osteoarthritis Drugs Market Competitive Situation and Trends

2.7.1 Osteoarthritis Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Osteoarthritis Drugs Players Market Share by Revenue

2.7.3 Global Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Osteoarthritis Drugs Retrospective Market Scenario by Region

3.1 Global Osteoarthritis Drugs Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Osteoarthritis Drugs Global Osteoarthritis Drugs Sales by Region: 2019-2030

3.2.1 Global Osteoarthritis Drugs Sales by Region: 2019-2024

3.2.2 Global Osteoarthritis Drugs Sales by Region: 2025-2030

3.3 Global Osteoarthritis Drugs Global Osteoarthritis Drugs Revenue by Region: 2019-2030

3.3.1 Global Osteoarthritis Drugs Revenue by Region: 2019-2024

3.3.2 Global Osteoarthritis Drugs Revenue by Region: 2025-2030

3.4 North America Osteoarthritis Drugs Market Facts & Figures by Country

3.4.1 North America Osteoarthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Osteoarthritis Drugs Sales by Country (2019-2030)

3.4.3 North America Osteoarthritis Drugs Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Osteoarthritis Drugs Market Facts & Figures by Country

3.5.1 Europe Osteoarthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Osteoarthritis Drugs Sales by Country (2019-2030)

3.5.3 Europe Osteoarthritis Drugs Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Osteoarthritis Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Osteoarthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Osteoarthritis Drugs Sales by Country (2019-2030)

3.6.3 Asia Pacific Osteoarthritis Drugs Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Osteoarthritis Drugs Market Facts & Figures by Country

3.7.1 Latin America Osteoarthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Osteoarthritis Drugs Sales by Country (2019-2030)

3.7.3 Latin America Osteoarthritis Drugs Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Osteoarthritis Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Osteoarthritis Drugs Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Osteoarthritis Drugs Sales by Country (2019-2030)

3.8.3 Middle East and Africa Osteoarthritis Drugs Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Osteoarthritis Drugs Sales by Type (2019-2030)

4.1.1 Global Osteoarthritis Drugs Sales by Type (2019-2024)

4.1.2 Global Osteoarthritis Drugs Sales by Type (2025-2030)

4.1.3 Global Osteoarthritis Drugs Sales Market Share by Type (2019-2030)

4.2 Global Osteoarthritis Drugs Revenue by Type (2019-2030)

4.2.1 Global Osteoarthritis Drugs Revenue by Type (2019-2024)

4.2.2 Global Osteoarthritis Drugs Revenue by Type (2025-2030)

4.2.3 Global Osteoarthritis Drugs Revenue Market Share by Type (2019-2030)

4.3 Global Osteoarthritis Drugs Price by Type (2019-2030)

5 Segment by Application

5.1 Global Osteoarthritis Drugs Sales by Application (2019-2030)

5.1.1 Global Osteoarthritis Drugs Sales by Application (2019-2024)

5.1.2 Global Osteoarthritis Drugs Sales by Application (2025-2030)

5.1.3 Global Osteoarthritis Drugs Sales Market Share by Application (2019-2030)

5.2 Global Osteoarthritis Drugs Revenue by Application (2019-2030)

5.2.1 Global Osteoarthritis Drugs Revenue by Application (2019-2024)

5.2.2 Global Osteoarthritis Drugs Revenue by Application (2025-2030)

5.2.3 Global Osteoarthritis Drugs Revenue Market Share by Application (2019-2030)

5.3 Global Osteoarthritis Drugs Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Johnson & Johnson

6.1.1 Johnson & Johnson Corporation Information

6.1.2 Johnson & Johnson Description and Business Overview

6.1.3 Johnson & Johnson Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Johnson & Johnson Osteoarthritis Drugs Product Portfolio

6.1.5 Johnson & Johnson Recent Developments/Updates

6.2 Pfizer

6.2.1 Pfizer Corporation Information

6.2.2 Pfizer Description and Business Overview

6.2.3 Pfizer Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Pfizer Osteoarthritis Drugs Product Portfolio

6.2.5 Pfizer Recent Developments/Updates

6.3 Eli Lilly

6.3.1 Eli Lilly Corporation Information

6.3.2 Eli Lilly Description and Business Overview

6.3.3 Eli Lilly Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Eli Lilly Osteoarthritis Drugs Product Portfolio

6.3.5 Eli Lilly Recent Developments/Updates

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Description and Business Overview

6.4.3 Abbott Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Abbott Osteoarthritis Drugs Product Portfolio

6.4.5 Abbott Recent Developments/Updates

6.5 GlaxoSmithKline

6.5.1 GlaxoSmithKline Corporation Information

6.5.2 GlaxoSmithKline Description and Business Overview

6.5.3 GlaxoSmithKline Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.5.4 GlaxoSmithKline Osteoarthritis Drugs Product Portfolio

6.5.5 GlaxoSmithKline Recent Developments/Updates

6.6 Sanofi

6.6.1 Sanofi Corporation Information

6.6.2 Sanofi Description and Business Overview

6.6.3 Sanofi Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Sanofi Osteoarthritis Drugs Product Portfolio

6.6.5 Sanofi Recent Developments/Updates

6.7 Flexion Therapeutics

6.6.1 Flexion Therapeutics Corporation Information

6.6.2 Flexion Therapeutics Description and Business Overview

6.6.3 Flexion Therapeutics Osteoarthritis Drugs Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Flexion Therapeutics Osteoarthritis Drugs Product Portfolio

6.7.5 Flexion Therapeutics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Osteoarthritis Drugs Industry Chain Analysis

7.2 Osteoarthritis Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Osteoarthritis Drugs Production Mode & Process

7.4 Osteoarthritis Drugs Sales and Marketing

7.4.1 Osteoarthritis Drugs Sales Channels

7.4.2 Osteoarthritis Drugs Distributors

7.5 Osteoarthritis Drugs Customers

8 Osteoarthritis Drugs Market Dynamics

8.1 Osteoarthritis Drugs Industry Trends

8.2 Osteoarthritis Drugs Market Drivers

8.3 Osteoarthritis Drugs Market Challenges

8.4 Osteoarthritis Drugs Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Osteoarthritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Osteoarthritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Osteoarthritis Drugs Market Competitive Situation by Manufacturers in 2023

Table 4. Global Osteoarthritis Drugs Sales (MT) of Key Manufacturers (2019-2024)

Table 5. Global Osteoarthritis Drugs Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Osteoarthritis Drugs Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Osteoarthritis Drugs Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Osteoarthritis Drugs Average Price (USD/Kg) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Osteoarthritis Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Osteoarthritis Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Osteoarthritis Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Osteoarthritis Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Osteoarthritis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Drugs as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Osteoarthritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Osteoarthritis Drugs Sales by Region (2019-2024) & (MT)

Table 18. Global Osteoarthritis Drugs Sales Market Share by Region (2019-2024)

Table 19. Global Osteoarthritis Drugs Sales by Region (2025-2030) & (MT)

Table 20. Global Osteoarthritis Drugs Sales Market Share by Region (2025-2030)

Table 21. Global Osteoarthritis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Osteoarthritis Drugs Revenue Market Share by Region (2019-2024)

Table 23. Global Osteoarthritis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Osteoarthritis Drugs Revenue Market Share by Region (2025-2030)

Table 25. North America Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 27. North America Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 28. North America Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 32. Europe Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 33. Europe Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Osteoarthritis Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Osteoarthritis Drugs Sales by Region (2019-2024) & (MT)

Table 37. Asia Pacific Osteoarthritis Drugs Sales by Region (2025-2030) & (MT)

Table 38. Asia Pacific Osteoarthritis Drugs Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Osteoarthritis Drugs Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 42. Latin America Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 43. Latin America Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Osteoarthritis Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Osteoarthritis Drugs Sales by Country (2019-2024) & (MT)

Table 47. Middle East & Africa Osteoarthritis Drugs Sales by Country (2025-2030) & (MT)

Table 48. Middle East & Africa Osteoarthritis Drugs Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Osteoarthritis Drugs Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Osteoarthritis Drugs Sales (MT) by Type (2019-2024)

Table 51. Global Osteoarthritis Drugs Sales (MT) by Type (2025-2030)

Table 52. Global Osteoarthritis Drugs Sales Market Share by Type (2019-2024)

Table 53. Global Osteoarthritis Drugs Sales Market Share by Type (2025-2030)

Table 54. Global Osteoarthritis Drugs Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Osteoarthritis Drugs Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Osteoarthritis Drugs Revenue Market Share by Type (2019-2024)

Table 57. Global Osteoarthritis Drugs Revenue Market Share by Type (2025-2030)

Table 58. Global Osteoarthritis Drugs Price (USD/Kg) by Type (2019-2024)

Table 59. Global Osteoarthritis Drugs Price (USD/Kg) by Type (2025-2030)

Table 60. Global Osteoarthritis Drugs Sales (MT) by Application (2019-2024)

Table 61. Global Osteoarthritis Drugs Sales (MT) by Application (2025-2030)

Table 62. Global Osteoarthritis Drugs Sales Market Share by Application (2019-2024)

Table 63. Global Osteoarthritis Drugs Sales Market Share by Application (2025-2030)

Table 64. Global Osteoarthritis Drugs Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Osteoarthritis Drugs Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Osteoarthritis Drugs Revenue Market Share by Application (2019-2024)

Table 67. Global Osteoarthritis Drugs Revenue Market Share by Application (2025-2030)

Table 68. Global Osteoarthritis Drugs Price (USD/Kg) by Application (2019-2024)

Table 69. Global Osteoarthritis Drugs Price (USD/Kg) by Application (2025-2030)

Table 70. Johnson & Johnson Corporation Information

Table 71. Johnson & Johnson Description and Business Overview

Table 72. Johnson & Johnson Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 73. Johnson & Johnson Osteoarthritis Drugs Product

Table 74. Johnson & Johnson Recent Developments/Updates

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 78. Pfizer Osteoarthritis Drugs Product

Table 79. Pfizer Recent Developments/Updates

Table 80. Eli Lilly Corporation Information

Table 81. Eli Lilly Description and Business Overview

Table 82. Eli Lilly Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 83. Eli Lilly Osteoarthritis Drugs Product

Table 84. Eli Lilly Recent Developments/Updates

Table 85. Abbott Corporation Information

Table 86. Abbott Description and Business Overview

Table 87. Abbott Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 88. Abbott Osteoarthritis Drugs Product

Table 89. Abbott Recent Developments/Updates

Table 90. GlaxoSmithKline Corporation Information

Table 91. GlaxoSmithKline Description and Business Overview

Table 92. GlaxoSmithKline Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 93. GlaxoSmithKline Osteoarthritis Drugs Product

Table 94. GlaxoSmithKline Recent Developments/Updates

Table 95. Sanofi Corporation Information

Table 96. Sanofi Description and Business Overview

Table 97. Sanofi Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 98. Sanofi Osteoarthritis Drugs Product

Table 99. Sanofi Recent Developments/Updates

Table 100. Flexion Therapeutics Corporation Information

Table 101. Flexion Therapeutics Description and Business Overview

Table 102. Flexion Therapeutics Osteoarthritis Drugs Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 103. Flexion Therapeutics Osteoarthritis Drugs Product

Table 104. Flexion Therapeutics Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Osteoarthritis Drugs Distributors List

Table 108. Osteoarthritis Drugs Customers List

Table 109. Osteoarthritis Drugs Market Trends

Table 110. Osteoarthritis Drugs Market Drivers

Table 111. Osteoarthritis Drugs Market Challenges

Table 112. Osteoarthritis Drugs Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Osteoarthritis Drugs

Figure 2. Global Osteoarthritis Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Osteoarthritis Drugs Market Share by Type in 2023 & 2030

Figure 4. Oral Product Picture

Figure 5. Injection Product Picture

Figure 6. External Product Picture

Figure 7. Global Osteoarthritis Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Osteoarthritis Drugs Market Share by Application in 2023 & 2030

Figure 9. Hospital Pharmacies

Figure 10. Retail Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Osteoarthritis Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Osteoarthritis Drugs Market Size (2019-2030) & (US$ Million)

Figure 14. Global Osteoarthritis Drugs Sales (2019-2030) & (MT)

Figure 15. Global Osteoarthritis Drugs Average Price (USD/Kg) & (2019-2030)

Figure 16. Osteoarthritis Drugs Report Years Considered

Figure 17. Osteoarthritis Drugs Sales Share by Manufacturers in 2023

Figure 18. Global Osteoarthritis Drugs Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Osteoarthritis Drugs Players: Market Share by Revenue in 2023

Figure 20. Osteoarthritis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Osteoarthritis Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Osteoarthritis Drugs Sales Market Share by Country (2019-2030)

Figure 23. North America Osteoarthritis Drugs Revenue Market Share by Country (2019-2030)

Figure 24. U.S. Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Osteoarthritis Drugs Sales Market Share by Country (2019-2030)

Figure 27. Europe Osteoarthritis Drugs Revenue Market Share by Country (2019-2030)

Figure 28. Germany Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Osteoarthritis Drugs Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Osteoarthritis Drugs Revenue Market Share by Region (2019-2030)

Figure 35. China Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Taiwan Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Philippines Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Osteoarthritis Drugs Sales Market Share by Country (2019-2030)

Figure 46. Latin America Osteoarthritis Drugs Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Osteoarthritis Drugs Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Osteoarthritis Drugs Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. U.A.E Osteoarthritis Drugs Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Osteoarthritis Drugs by Type (2019-2030)

Figure 56. Global Revenue Market Share of Osteoarthritis Drugs by Type (2019-2030)

Figure 57. Global Osteoarthritis Drugs Price (USD/Kg) by Type (2019-2030)

Figure 58. Global Sales Market Share of Osteoarthritis Drugs by Application (2019-2030)

Figure 59. Global Revenue Market Share of Osteoarthritis Drugs by Application (2019-2030)

Figure 60. Global Osteoarthritis Drugs Price (USD/Kg) by Application (2019-2030)

Figure 61. Osteoarthritis Drugs Value Chain

Figure 62. Osteoarthritis Drugs Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Viscosupplementation for Knee Osteoarthritis Market

Knee Osteoarthritis Treatment Market

Osteoarthritis Pain Market

Osteoarthritis Drugs Market

Osteoarthritis Medications Market

Hip Replacement Market

Rheumatology Therapeutics Market

Total Hip Replacement Market

Psoriatic Arthritis Therapeutics Market

Digital Therapeutics Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions